EVALUATION OF STRONTIUM-89 IN PALLIATIVE TREATMENT OF WIDESPREAD AND PAINFUL BONE METASTASES DUE TO BREAST AND PROSTATE CANCER

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

GHADIRI F.; HADAD P.; MEHDI FAR J.; ZERAATI HOJAT

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: IRANIAN JOURNAL OF NUCLEAR MEDICINE Year:2000 | Volume:- | Issue:12-13 Page(s): 54-61

Download Full-Text

View:

220

Download:

Cites:

Information Journal Paper

Title

EVALUATION OF STRONTIUM-89 IN PALLIATIVE TREATMENT OF WIDESPREAD AND PAINFUL BONE METASTASES DUE TO BREAST AND PROSTATE CANCER

Author(s)

GHADIRI F. | HADAD P. | MEHDI FAR J. | ZERAATI HOJAT | Issue Writer Certificate

Keywords

BONE METASTASES

RADIONUCLIDE THERAPY

RADIOTHERAPY

STRONTIUM-89

BREAST CANCER

PROSTATE CANCER

Abstract

Treatment of BONE METASTASES comprises over 10% of the workload of a radiation-oncology center. BONE METASTASES produce severe pain and immobility, necessitate narcotic use, and reduce the quality of life. A good palliative treatment must be complete, free from side effects and fast; Thus we decided to evaluate STRONTIUM-89 (89Sr) affectivity for palliation of breast and PROSTATE CANCER BONE METASTASES in relation to above factors. The use of 89Sr RADIONUCLIDE THERAPY started on 1992 in radiation-oncology department of Cancer Institute. Until early 1999, 91 patients with bone metstases have been treated for pain relief in our department with 4 mCi of 89Sr. Of these, 80 were breast and prostate metastatic cancers. 35 patients came back for follow-up and were completely evaluated. Response was seen in 65% of patients (Complete response in 40% and partial response in 25%). Side effects were negligible, and quality of life of the responding patients significantly increased. There was no significant relationship between the type of primary cancer or patient age and response. In conclusion, treatment of metastatic bone cancer from prostate and breast primaries in our department was effective, with a relatively high rate of response and no serious side effects.

Cites

No record.

References

No record.

Cite

APA: Copy

GHADIRI, F., HADAD, P., MEHDI FAR, J., & ZERAATI, HOJAT. (2000). EVALUATION OF STRONTIUM-89 IN PALLIATIVE TREATMENT OF WIDESPREAD AND PAINFUL BONE METASTASES DUE TO BREAST AND PROSTATE CANCER. IRANIAN JOURNAL OF NUCLEAR MEDICINE, -(12-13), 54-61. SID. https://sid.ir/paper/556422/en

Vancouver: Copy

GHADIRI F., HADAD P., MEHDI FAR J., ZERAATI HOJAT. EVALUATION OF STRONTIUM-89 IN PALLIATIVE TREATMENT OF WIDESPREAD AND PAINFUL BONE METASTASES DUE TO BREAST AND PROSTATE CANCER. IRANIAN JOURNAL OF NUCLEAR MEDICINE[Internet]. 2000;-(12-13):54-61. Available from: https://sid.ir/paper/556422/en

IEEE: Copy

F. GHADIRI, P. HADAD, J. MEHDI FAR, and HOJAT ZERAATI, “EVALUATION OF STRONTIUM-89 IN PALLIATIVE TREATMENT OF WIDESPREAD AND PAINFUL BONE METASTASES DUE TO BREAST AND PROSTATE CANCER,” IRANIAN JOURNAL OF NUCLEAR MEDICINE, vol. -, no. 12-13, pp. 54–61, 2000, [Online]. Available: https://sid.ir/paper/556422/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops